| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 3.328 | 17.616 | 23.470 | 26.626 | 8.976 |
| Total Income - EUR | - | - | - | - | - | 3.328 | 17.893 | 23.479 | 29.519 | 8.976 |
| Total Expenses - EUR | - | - | - | - | - | 6 | 5.875 | 3.639 | 11.255 | 5.526 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 3.322 | 12.018 | 19.840 | 18.264 | 3.450 |
| Net Profit/Loss - EUR | - | - | - | - | - | 3.222 | 11.547 | 19.494 | 18.045 | 2.981 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Dr. Qatawneh Corina S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 14.026 | 12.186 |
| Current Assets | - | - | - | - | - | 3.364 | 19.184 | 25.737 | 43.902 | 50.280 |
| Inventories | - | - | - | - | - | 0 | 0 | 576 | 1.203 | 1.196 |
| Receivables | - | - | - | - | - | 0 | 722 | 24.432 | 24.822 | 46.955 |
| Cash | - | - | - | - | - | 3.364 | 18.462 | 730 | 17.876 | 2.130 |
| Shareholders Funds | - | - | - | - | - | 3.264 | 14.738 | 19.535 | 37.521 | 40.292 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 100 | 4.446 | 6.202 | 20.407 | 22.174 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Qatawneh Corina S.r.l.